Matilda Houston

Matilda Houston

Auto-generated profile, based on publicly available information

Matilda Houston

Institute for Biomedicine and Glycomics, Griffith University, Gold Coast, QLD 4215, Australia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
MHMatilda Lea Houston
Matilda Lea Houston
JMJody Morgan
Jody Morgan
CKCeline Kelso
Celine Kelso
Background: Synthetic cannabinoid receptor agonists (SCRAs) are the most diverse class of new psychoactive substances worldwide, with approximately 300 unique SCRAs identified to date. While the use of this class of drug is not particularly prevalent, SCRAs are associated with several deaths every year due to their severe toxicity. Methods: A thorough examination of the literature identified 15 new SCRAs with a significant clinical impact between 2015 and 2021. Results: These 15 SCRAs have been implicated in 154 hospitalizations and 209 deaths across the US, Europe, Asia, and Australasia during this time period. Conclusion: This narrative review provides pharmacodynamic, pharmacokinetic, and toxicologic data for SCRAs as a drug class, including an in-depth review of known pharmacological properties of 15 recently identified and emerging SCRAs for the benefit of researchers, policy makers, and clinicians who wish to be informed of developments in this field.

27 April 2022 in medRxiv
Verified
Preprint
Open access
PDF file
JMJody Morgan
Jody Morgan
GGGrace Gschwend
Grace Gschwend
MHMatilda Houston
Matilda Houston
AJAlison Jones
Alison Jones
CKCeline Kelso
Celine Kelso
In 2019 an estimated 200 million people aged 15-64 used cannabis, making cannabis the most prevalent illicit substance worldwide. The last decade has seen a significant expansion in the cannabis vaporiser market, introducing cannabis vaporisation as a common administration method alongside smoking and ingestion. Despite reports of increased prevalence of cannabis vaporisation there has been little research into the use of these devices. To remedy the current dearth of data in this area this study utilised an anonymous online survey of individuals who self-reported past cannabis vaporisation. The respondents (N=557) were predominantly young (<35 years) and male. Most (91.4%) stated they had ever vaped dry herb cannabis, 59.1% reported vaporisation of cannabis oil or liquids, and 34.0% reported vaporisation of cannabis concentrates. This study identifies the types of vaporisation devices (including brands and models) employed by cannabis vapers, as well as the vaporisation temperatures and puff durations commonly used for dry herb, cannabis liquids and cannabis concentrates. To the best of our knowledge, this is the first time the usual operating temperatures of these vaporisation devices and user specific consumption patterns such as puff duration have been reported for cannabis vaping. This information will allow for more realistic experimental conditions in research settings.

23 September 2026 in Molecules
Verified
Journal Article
Open access
PDF file
TJTabassum Jannat
Tabassum Jannat
Jianying HanJianying Han
Jianying Han
MHMatilda Houston
Matilda Houston
TMTin Mak
Tin Mak
JWJohn Watson
John Watson
RQRonald J Quinn
Ronald J Quinn
Mudjala bark, prepared from Barringtonia acutangula, is an Australian Aboriginal medicine traditionally used for pain relief, and previous studies have associated its activity with triterpenoid-rich fractions. However, the low-molecular-weight triterpenoids, which were major chromatographic constituents in these fractions, remained chemically unresolved. In this study, we define the aglycone-rich triterpenoid profile of Australian Mudjala bark and resolve its dominant inseparable aglycone mixture. The two major chromatographic isomeric acidic triterpenes could not be separated directly by reversed-phase HPLC, but isolation and hydrolysis of their corresponding C-28 glucosides enabled their assignment as bartogenic acid (1) and trachelosperogenin A (2). Overall, thirteen triterpenoids were assigned, including one new acylated barringtogenol C-type aglycone (5) and twelve known compounds (1–4, 6–13). The profile comprises three main chemical domains: 24,28-dioic acid aglycones and C-28 glucosides, acylated barringtogenol C-type oleananes, and common pentacyclic triterpene acids. These findings establish a compound-level chemical framework for the previously bioactive low-molecular-weight Mudjala fraction and support future quantitative and biological investigation.